Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Autologous Transplantation
100%
Tumor Cell Mobilization
100%
Transplantation
50%
Hematological Malignancies
50%
Acute Myeloid Leukemia
50%
Multiple Myeloma
50%
Non-Hodgkin Lymphoma
50%
Diagnostic Tool
25%
Tumor
25%
Clinical Outcomes
25%
Response Rate
25%
Progression-free Survival
25%
Tumor Cells
25%
Overall Survival
25%
Chemotherapy
25%
Stem Cells
25%
Granulocyte Colony-stimulating Factor (G-CSF)
25%
Reconstitution
25%
Peripheral Blood
25%
Treatment Paradigms
25%
Minimal Residual Disease
25%
Blood Cells
25%
Impact Response
25%
High-dose Chemotherapy
25%
Contamination Risk
25%
Autologous Peripheral Blood Stem Cells
25%
Mobilization Regimen
25%
Peripheral Blood Hematopoietic Stem Cells
25%
Residual Disease
25%
Chemosensitivity
25%
Medicine and Dentistry
Tumor Cell
100%
Cytokine
40%
Hematologic Malignancy
40%
Acute Myeloid Leukemia
40%
Non-Hodgkin Lymphoma
40%
Multiple Myeloma
40%
Minimal Residual Disease
40%
Neoplasm
20%
Progression Free Survival
20%
Overall Survival
20%
Autotransplantation
20%
Stem Cell
20%
Granulocyte Colony Stimulating Factor
20%
High Dose Chemotherapy
20%
Peripheral Blood Stem Cell
20%
Chemosensitivity
20%
Hematopoietic Cell
20%
Chemotherapy
20%
Diagnosis
20%
Immunology and Microbiology
Tumor Cell
100%
Cytokine
40%
Myeloid
40%
Multiple Myeloma
40%
Hematopoietic Cell
20%
Drug Megadose
20%
Stem Cell
20%
Overall Survival
20%
Granulocyte Colony-Stimulating Factor
20%
Peripheral Blood Stem Cell
20%
Progression Free Survival
20%
Autotransplantation
20%
Chemosensitivity
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Hematologic Malignancy
33%
Cytokine
33%
Multiple Myeloma
33%
Nonhodgkin Lymphoma
33%
Acute Myeloid Leukemia
33%
Minimal Residual Disease
33%
Progression Free Survival
16%
Overall Survival
16%
Granulocyte Colony Stimulating Factor
16%
Chemotherapy Regimens
16%
High Dose Chemotherapy
16%